Cohance Lifesciences Limited has informed the Exchange about Letter to Shareholders regarding Annual Report
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences (formerly Suven Pharmaceuticals) has informed the stock exchanges that it is sending a letter to shareholders whose email addresses are not registered with the company, its RTA (KFintech), or their Depository Participants, providing them the weblink to access the Annual Report for FY2024-25. The 7th Annual General Meeting is scheduled for Friday, September 19, 2025 at 2:30 p.m. IST and will be held via Video Conference / Other Audio-Visual Means. The Annual Report is available on the company's website at suvenpharm.com under Investors > Financial Info > FY2025. The company also reminded shareholders to update their PAN, KYC, and nomination details, and noted that dividends may be withheld for folios with incomplete KYC. A dedicated Senior Citizens Investor Cell with a toll-free number (1800 3094 006) has been set up to assist senior citizen shareholders.
This is a routine regulatory disclosure under SEBI's Listing Regulations and does not have any material impact on the stock price or business outlook. Shareholders should ensure their email and KYC details are updated to receive future communications, dividends, and AGM participation links.